Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03780387Phase 1Terminated
Phase 1, open-label, single-arm trial, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Maximum Change in the Percentage of Forced Expiratory Volume in 1 Second (FEV1). Started Apr 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03780387.